News Sought-after obesity drug Wegovy backed for NHS use Use is restricted to two years in patients enrolled in NHS weight management services.
News Ex-NHS chief negotiator joins Newmarket Strategy Pharma veteran Blake Dark joins the healthcare and life sciences consultancy as senior partner.
News More digital mental health therapies backed for NHS use Online CBT programmes could help 40,000 people with depression and anxiety-related conditions.
News NICE okays neoadjuvant Opdivo in lung cancer BMS' checkpoint inhibitor is first to be given a green light for use before surgery in NSCLC.
News As pandemic abates, NICE issues new COVID drug guidance NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.
News NICE won’t back AZ’s Evusheld for COVID prevention Blood Cancer UK calls for help for the 'forgotten 500,000' who can't be protected with vaccines
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
